Selected research
Market Analysis & Forecast
Global Ketorolac Tromethamine Tablets Market Analysis and Forecast 2026-2032
Market perspective
The global Ketorolac Tromethamine Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Ketorolac Tromethamine Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Ketorolac Tromethamine Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Ketorolac Tromethamine Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Ketorolac Tromethamine Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Ketorolac Tromethamine Tablets include Shandong New Era Pharmaceutical, Teva Pharmaceuticals, TC Pharmaceuticals (Jiangsu), Chengdu Brilliant Pharmaceutical, Dr. Reddy's Laboratories and AdvaCare Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Ketorolac Tromethamine Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Ketorolac Tromethamine Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Ketorolac Tromethamine Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Ketorolac Tromethamine Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ketorolac Tromethamine Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ketorolac Tromethamine Tablets sales, projected growth trends, production technology, application and end-user industry.
Ketorolac Tromethamine Tablets Segment by Company
Shandong New Era Pharmaceutical
Teva Pharmaceuticals
TC Pharmaceuticals (Jiangsu)
Chengdu Brilliant Pharmaceutical
Dr. Reddy's Laboratories
AdvaCare Pharma
Ketorolac Tromethamine Tablets Segment by Type
100 Tablets
150 Tablets
Others
Ketorolac Tromethamine Tablets Segment by Application
Hospital
Clinic
Others
Ketorolac Tromethamine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Tromethamine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Tromethamine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Tromethamine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Ketorolac Tromethamine Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Ketorolac Tromethamine Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ketorolac Tromethamine Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100 Tablets
- 150 Tablets
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Shandong New Era Pharmaceutical
- Teva Pharmaceuticals
- TC Pharmaceuticals (Jiangsu)
- Chengdu Brilliant Pharmaceutical
- Dr. Reddy's Laboratories
- AdvaCare Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Ketorolac Tromethamine Tablets Market by Type
- 1.2.1 Global Ketorolac Tromethamine Tablets Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 100 Tablets
- 1.2.3 150 Tablets
- 1.2.4 Others
- 1.3 Ketorolac Tromethamine Tablets Market by Application
- 1.3.1 Global Ketorolac Tromethamine Tablets Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Ketorolac Tromethamine Tablets Market Dynamics
- 2.1 Ketorolac Tromethamine Tablets Industry Trends
- 2.2 Ketorolac Tromethamine Tablets Industry Drivers
- 2.3 Ketorolac Tromethamine Tablets Industry Opportunities and Challenges
- 2.4 Ketorolac Tromethamine Tablets Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Ketorolac Tromethamine Tablets Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Ketorolac Tromethamine Tablets Revenue by Region
- 3.2.1 Global Ketorolac Tromethamine Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Ketorolac Tromethamine Tablets Revenue by Region (2021-2026)
- 3.2.3 Global Ketorolac Tromethamine Tablets Revenue by Region (2027-2032)
- 3.2.4 Global Ketorolac Tromethamine Tablets Revenue Market Share by Region (2021-2032)
- 3.3 Global Ketorolac Tromethamine Tablets Sales Estimates and Forecasts 2021-2032
- 3.4 Global Ketorolac Tromethamine Tablets Sales by Region
- 3.4.1 Global Ketorolac Tromethamine Tablets Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Ketorolac Tromethamine Tablets Sales by Region (2021-2026)
- 3.4.3 Global Ketorolac Tromethamine Tablets Sales by Region (2027-2032)
- 3.4.4 Global Ketorolac Tromethamine Tablets Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Ketorolac Tromethamine Tablets Revenue by Manufacturers
- 4.1.1 Global Ketorolac Tromethamine Tablets Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Ketorolac Tromethamine Tablets Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Ketorolac Tromethamine Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Ketorolac Tromethamine Tablets Sales by Manufacturers
- 4.2.1 Global Ketorolac Tromethamine Tablets Sales by Manufacturers (2021-2026)
- 4.2.2 Global Ketorolac Tromethamine Tablets Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Ketorolac Tromethamine Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Ketorolac Tromethamine Tablets Sales Price by Manufacturers (2021-2026)
- 4.4 Global Ketorolac Tromethamine Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Ketorolac Tromethamine Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Ketorolac Tromethamine Tablets Manufacturers, Product Type & Application
- 4.7 Global Ketorolac Tromethamine Tablets Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Ketorolac Tromethamine Tablets Market CR5 and HHI
- 4.8.2 2025 Ketorolac Tromethamine Tablets Tier 1, Tier 2, and Tier 3
5 Ketorolac Tromethamine Tablets Market by Type
- 5.1 Global Ketorolac Tromethamine Tablets Revenue by Type
- 5.1.1 Global Ketorolac Tromethamine Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Ketorolac Tromethamine Tablets Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Ketorolac Tromethamine Tablets Revenue Market Share by Type (2021-2032)
- 5.2 Global Ketorolac Tromethamine Tablets Sales by Type
- 5.2.1 Global Ketorolac Tromethamine Tablets Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Ketorolac Tromethamine Tablets Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Ketorolac Tromethamine Tablets Sales Market Share by Type (2021-2032)
- 5.3 Global Ketorolac Tromethamine Tablets Price by Type
6 Ketorolac Tromethamine Tablets Market by Application
- 6.1 Global Ketorolac Tromethamine Tablets Revenue by Application
- 6.1.1 Global Ketorolac Tromethamine Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Ketorolac Tromethamine Tablets Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Ketorolac Tromethamine Tablets Revenue Market Share by Application (2021-2032)
- 6.2 Global Ketorolac Tromethamine Tablets Sales by Application
- 6.2.1 Global Ketorolac Tromethamine Tablets Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Ketorolac Tromethamine Tablets Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Ketorolac Tromethamine Tablets Sales Market Share by Application (2021-2032)
- 6.3 Global Ketorolac Tromethamine Tablets Price by Application
7 Company Profiles
- 7.1 Shandong New Era Pharmaceutical
- 7.1.1 Shandong New Era Pharmaceutical Company Information
- 7.1.2 Shandong New Era Pharmaceutical Business Overview
- 7.1.3 Shandong New Era Pharmaceutical Ketorolac Tromethamine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Shandong New Era Pharmaceutical Ketorolac Tromethamine Tablets Product Portfolio
- 7.1.5 Shandong New Era Pharmaceutical Recent Developments
- 7.2 Teva Pharmaceuticals
- 7.2.1 Teva Pharmaceuticals Company Information
- 7.2.2 Teva Pharmaceuticals Business Overview
- 7.2.3 Teva Pharmaceuticals Ketorolac Tromethamine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Teva Pharmaceuticals Ketorolac Tromethamine Tablets Product Portfolio
- 7.2.5 Teva Pharmaceuticals Recent Developments
- 7.3 TC Pharmaceuticals (Jiangsu)
- 7.3.1 TC Pharmaceuticals (Jiangsu) Company Information
- 7.3.2 TC Pharmaceuticals (Jiangsu) Business Overview
- 7.3.3 TC Pharmaceuticals (Jiangsu) Ketorolac Tromethamine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 TC Pharmaceuticals (Jiangsu) Ketorolac Tromethamine Tablets Product Portfolio
- 7.3.5 TC Pharmaceuticals (Jiangsu) Recent Developments
- 7.4 Chengdu Brilliant Pharmaceutical
- 7.4.1 Chengdu Brilliant Pharmaceutical Company Information
- 7.4.2 Chengdu Brilliant Pharmaceutical Business Overview
- 7.4.3 Chengdu Brilliant Pharmaceutical Ketorolac Tromethamine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Chengdu Brilliant Pharmaceutical Ketorolac Tromethamine Tablets Product Portfolio
- 7.4.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 7.5 Dr. Reddy's Laboratories
- 7.5.1 Dr. Reddy's Laboratories Company Information
- 7.5.2 Dr. Reddy's Laboratories Business Overview
- 7.5.3 Dr. Reddy's Laboratories Ketorolac Tromethamine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Dr. Reddy's Laboratories Ketorolac Tromethamine Tablets Product Portfolio
- 7.5.5 Dr. Reddy's Laboratories Recent Developments
- 7.6 AdvaCare Pharma
- 7.6.1 AdvaCare Pharma Company Information
- 7.6.2 AdvaCare Pharma Business Overview
- 7.6.3 AdvaCare Pharma Ketorolac Tromethamine Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 AdvaCare Pharma Ketorolac Tromethamine Tablets Product Portfolio
- 7.6.5 AdvaCare Pharma Recent Developments
8 North America
- 8.1 North America Ketorolac Tromethamine Tablets Market Size by Type
- 8.1.1 North America Ketorolac Tromethamine Tablets Revenue by Type (2021-2032)
- 8.1.2 North America Ketorolac Tromethamine Tablets Sales by Type (2021-2032)
- 8.1.3 North America Ketorolac Tromethamine Tablets Price by Type (2021-2032)
- 8.2 North America Ketorolac Tromethamine Tablets Market Size by Application
- 8.2.1 North America Ketorolac Tromethamine Tablets Revenue by Application (2021-2032)
- 8.2.2 North America Ketorolac Tromethamine Tablets Sales by Application (2021-2032)
- 8.2.3 North America Ketorolac Tromethamine Tablets Price by Application (2021-2032)
- 8.3 North America Ketorolac Tromethamine Tablets Market Size by Country
- 8.3.1 North America Ketorolac Tromethamine Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Ketorolac Tromethamine Tablets Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Ketorolac Tromethamine Tablets Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Ketorolac Tromethamine Tablets Market Size by Type
- 9.1.1 Europe Ketorolac Tromethamine Tablets Revenue by Type (2021-2032)
- 9.1.2 Europe Ketorolac Tromethamine Tablets Sales by Type (2021-2032)
- 9.1.3 Europe Ketorolac Tromethamine Tablets Price by Type (2021-2032)
- 9.2 Europe Ketorolac Tromethamine Tablets Market Size by Application
- 9.2.1 Europe Ketorolac Tromethamine Tablets Revenue by Application (2021-2032)
- 9.2.2 Europe Ketorolac Tromethamine Tablets Sales by Application (2021-2032)
- 9.2.3 Europe Ketorolac Tromethamine Tablets Price by Application (2021-2032)
- 9.3 Europe Ketorolac Tromethamine Tablets Market Size by Country
- 9.3.1 Europe Ketorolac Tromethamine Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Ketorolac Tromethamine Tablets Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Ketorolac Tromethamine Tablets Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Ketorolac Tromethamine Tablets Market Size by Type
- 10.1.1 China Ketorolac Tromethamine Tablets Revenue by Type (2021-2032)
- 10.1.2 China Ketorolac Tromethamine Tablets Sales by Type (2021-2032)
- 10.1.3 China Ketorolac Tromethamine Tablets Price by Type (2021-2032)
- 10.2 China Ketorolac Tromethamine Tablets Market Size by Application
- 10.2.1 China Ketorolac Tromethamine Tablets Revenue by Application (2021-2032)
- 10.2.2 China Ketorolac Tromethamine Tablets Sales by Application (2021-2032)
- 10.2.3 China Ketorolac Tromethamine Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Ketorolac Tromethamine Tablets Market Size by Type
- 11.1.1 Asia Ketorolac Tromethamine Tablets Revenue by Type (2021-2032)
- 11.1.2 Asia Ketorolac Tromethamine Tablets Sales by Type (2021-2032)
- 11.1.3 Asia Ketorolac Tromethamine Tablets Price by Type (2021-2032)
- 11.2 Asia Ketorolac Tromethamine Tablets Market Size by Application
- 11.2.1 Asia Ketorolac Tromethamine Tablets Revenue by Application (2021-2032)
- 11.2.2 Asia Ketorolac Tromethamine Tablets Sales by Application (2021-2032)
- 11.2.3 Asia Ketorolac Tromethamine Tablets Price by Application (2021-2032)
- 11.3 Asia Ketorolac Tromethamine Tablets Market Size by Country
- 11.3.1 Asia Ketorolac Tromethamine Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Ketorolac Tromethamine Tablets Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Ketorolac Tromethamine Tablets Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Ketorolac Tromethamine Tablets Market Size by Type
- 12.1.1 SAMEA Ketorolac Tromethamine Tablets Revenue by Type (2021-2032)
- 12.1.2 SAMEA Ketorolac Tromethamine Tablets Sales by Type (2021-2032)
- 12.1.3 SAMEA Ketorolac Tromethamine Tablets Price by Type (2021-2032)
- 12.2 SAMEA Ketorolac Tromethamine Tablets Market Size by Application
- 12.2.1 SAMEA Ketorolac Tromethamine Tablets Revenue by Application (2021-2032)
- 12.2.2 SAMEA Ketorolac Tromethamine Tablets Sales by Application (2021-2032)
- 12.2.3 SAMEA Ketorolac Tromethamine Tablets Price by Application (2021-2032)
- 12.3 SAMEA Ketorolac Tromethamine Tablets Market Size by Country
- 12.3.1 SAMEA Ketorolac Tromethamine Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Ketorolac Tromethamine Tablets Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Ketorolac Tromethamine Tablets Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Ketorolac Tromethamine Tablets Value Chain Analysis
- 13.1.1 Ketorolac Tromethamine Tablets Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Ketorolac Tromethamine Tablets Production Mode & Process
- 13.2 Ketorolac Tromethamine Tablets Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Ketorolac Tromethamine Tablets Distributors
- 13.2.3 Ketorolac Tromethamine Tablets Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst